Skip to content

VRCA - Verrica Pharmaceuticals Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchV

Verrica Pharmaceuticals Inc

VRCA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

V

VRCAVerrica Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $9.82
52-wk low: $3.28
Prev close: $6.52
Mkt cap: $85.7M
Beta: 1.49
P/S: 2.8x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$2.5M

MW
Marshall Wace
Q1 2026 13F
$743K
position
SQ
Squarepoint
Q1 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 14.9% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -102.8%
Market cap: $86M

Valuation

P/S2.83
P/B18.67

Quality

Operating margin-194.5%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: VRCA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $85.72M
Beta: 1.49

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

18.7x

Profit margin

-102.8%

Op margin

-194.5%

ROE

-240.4%

$398K

position

TS

Two Sigma

Q2 2026 13F

$250K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for VRCA

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.54-14.9%

-$0.47 expected

Next report

What the street expects next

EPS expected

-$0.54

-$0.57 to -$0.50

Revenue expected

$6.4M

6 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

0.11

Change in 30 days

-240.4%

ROA-44.0%

Growth

Beta1.49